Immunotherapy for Gestational Trophoblastic Neoplasia: A New Paradigm
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immunotherapy for Gestational Trophoblastic Neoplasia: A New Paradigm
Authors
Keywords
-
Journal
GYNECOLOGIC AND OBSTETRIC INVESTIGATION
Volume -, Issue -, Pages 1-9
Publisher
S. Karger AG
Online
2023-10-12
DOI
10.1159/000533972
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Novel approaches to managing gestational trophoblastic tumors in the age of immunotherapy
- (2023) Lindsay Hennah et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Anti-PD-1 therapy plus chemotherapy versus anti-PD-1 therapy alone in patients with high-risk chemorefractory or relapsed gestational trophoblastic neoplasia: a multicenter, retrospective study
- (2023) Xiaoyu Wang et al. EClinicalMedicine
- Effectiveness and Safety of Toripalimab Combination Therapies for Patients With Chemo-Resistant Choriocarcinoma
- (2022) Xiaomei Liu et al. Frontiers in Oncology
- Avelumab in patients with gestational trophoblastic tumors with resistance to polychemotherapy: Cohort B of the TROPHIMMUN phase 2 trial
- (2022) Benoit You et al. GYNECOLOGIC ONCOLOGY
- Anti-angiogenic agents — overcoming tumour endothelial cell anergy and improving immunotherapy outcomes
- (2021) Zowi R. Huinen et al. Nature Reviews Clinical Oncology
- Predictors for single-agent resistance in FIGO score 5 or 6 gestational trophoblastic neoplasia: a multicentre, retrospective, cohort study
- (2021) Antonio Braga et al. LANCET ONCOLOGY
- Term Pregnancy After Complete Response of Placental Site Trophoblastic Tumor to Immunotherapy
- (2021) Brock Polnaszek et al. OBSTETRICS AND GYNECOLOGY
- Outcomes of Pregnancy During Immunotherapy Treatment for Cancer: Analysis of Clinical Trials Sponsored by the National Cancer Institute
- (2021) Arjun Mittra et al. ONCOLOGIST
- Long-term survival in multiresistant metastatic choriocarcinoma after pembrolizumab treatment: A case report
- (2021) V. Paspalj et al. Gynecologic Oncology Reports
- An extrauterine extensively metastatic epithelioid trophoblastic tumor responsive to pembrolizumab
- (2021) Sarah G. Bell et al. Gynecologic Oncology Reports
- Combining immune checkpoint inhibitors with chemotherapy in advanced solid tumours: A review
- (2021) Mathieu Larroquette et al. EUROPEAN JOURNAL OF CANCER
- Immunotherapy for cancer treatment during pregnancy
- (2021) Jessica S W Borgers et al. LANCET ONCOLOGY
- Camrelizumab plus apatinib in patients with high-risk chemorefractory or relapsed gestational trophoblastic neoplasia (CAP 01): a single-arm, open-label, phase 2 trial
- (2021) Hongyan Cheng et al. LANCET ONCOLOGY
- Conception and viable twin pregnancy in a patient with metastatic melanoma while treated with CTLA-4 and PD-1 checkpoint inhibition
- (2020) Amanda D. Bucheit et al. MELANOMA RESEARCH
- Demographics, Natural History and Treatment Outcomes of Non‐Molar Gestational Choriocarcinoma; A UK population study
- (2020) Philip Savage et al. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
- Avelumab in Patients With Gestational Trophoblastic Tumors With Resistance to Single-Agent Chemotherapy: Cohort A of the TROPHIMMUN Phase II Trial
- (2020) Benoit You et al. JOURNAL OF CLINICAL ONCOLOGY
- The Challenges of Tumor Mutational Burden as an Immunotherapy Biomarker
- (2020) Denis L. Jardim et al. CANCER CELL
- Pregnancy with successful foetal and maternal outcome in a melanoma patient treated with nivolumab in the first trimester
- (2019) Wen Xu et al. MELANOMA RESEARCH
- Intensified therapies improve survival and identification of novel prognostic factors for placental-site and epithelioid trophoblastic tumours
- (2019) Fieke E. M. Froeling et al. BRITISH JOURNAL OF CANCER
- Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial
- (2019) Leonie Voorwerk et al. NATURE MEDICINE
- Effective anti-programmed cell death 1 treatment for chemoresistant gestational trophoblastic neoplasia
- (2019) Min Chul Choi et al. EUROPEAN JOURNAL OF CANCER
- Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
- (2018) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Viable Pregnancy in a patient with metastatic melanoma treated with double checkpoint immunotherapy
- (2018) Mauricio Burotto et al. SEMINARS IN ONCOLOGY
- Immunotherapy with ipilimumab plus nivolumab in a stage IV melanoma patient during pregnancy
- (2018) Christian Menzer et al. EUROPEAN JOURNAL OF CANCER
- Management and prognostic factors of epithelioid trophoblastic tumors: Results from the International Society for the Study of Trophoblastic Diseases database
- (2018) M.M. Frijstein et al. GYNECOLOGIC ONCOLOGY
- PD-L1 Expression in Premalignant and Malignant Trophoblasts From Gestational Trophoblastic Diseases Is Ubiquitous and Independent of Clinical Outcomes
- (2017) Pierre-Adrien Bolze et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Complete Serologic Response to Pembrolizumab in a Woman With Chemoresistant Metastatic Choriocarcinoma
- (2017) Marilyn Huang et al. JOURNAL OF CLINICAL ONCOLOGY
- Nivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057)
- (2017) Leora Horn et al. JOURNAL OF CLINICAL ONCOLOGY
- Pembrolizumab is effective for drug-resistant gestational trophoblastic neoplasia
- (2017) Ehsan Ghorani et al. LANCET
- Mortality rate of gestational trophoblastic neoplasia with a FIGO score of ≥13
- (2016) Pierre-Adrien Bolze et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Comprehensive Immunohistochemical Study of Programmed Cell Death Ligand 1 (PD-L1)
- (2016) Shingo Inaguma et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- PD-L1 Expression in Human Placentas and Gestational Trophoblastic Diseases
- (2016) Emanuela Veras et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- Tumor immune profiling predicts response to anti–PD-1 therapy in human melanoma
- (2016) Adil I. Daud et al. JOURNAL OF CLINICAL INVESTIGATION
- Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
- (2014) Roy S. Herbst et al. NATURE
- EMA/CO for High-Risk Gestational Trophoblastic Neoplasia: Good Outcomes With Induction Low-Dose Etoposide-Cisplatin and Genetic Analysis
- (2012) Constantine Alifrangis et al. JOURNAL OF CLINICAL ONCOLOGY
- An immune-active tumor microenvironment favors clinical response to ipilimumab
- (2011) Rui-Ru Ji et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prognostic markers and long-term outcome of placental-site trophoblastic tumours: a retrospective observational study
- (2009) Peter Schmid et al. LANCET
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search